Grifols shares sink

Grifols shares tumble after Brookfield drops takeover plan
Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over the pharmaceutical company's value, while Grifols said it concurred with the decision.
Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols
Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over the Spanish blood-plasma company.
Grifols shares sink after Brookfield walks away from €6.45bn offer
Brookfield Asset Management has walked away from an acquisition of Spanish healthcare group Grifols after months of negotiations, sending shares in the short seller target down almost 13 per cent.
Brookfield abandons plan for €6.45-billion takeover of drug maker Grifols
Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price
Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at $7.14 in premarket trading. Shares had already fallen nearly 25% year-to-date when the market closed Tuesday.
Grifols shares drop as buyer Brookfield loses interest — report
Grifols share price dropped by more than a tenth on Wednesday on reports that suitor Brookfield was considering dropping its planned takeover of the Spanish healthcare group.
Grifols Board Issues Unfavorable Opinion on Brookfield Offer
Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative offer, which values the Spanish drugmaker at €6.45 billion ($6.8 billion).Most Read from BloombergParis to Replace Parking Spaces With TreesNew York’s Transit Agency Approves $9 Congestion TollIn Cleveland,
Grifols shares tumble after report on Brookfield abandoning takeover plan
Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping its plan to take over the Spanish pharmaceutical firm.The Canadian private equity firm is walking away on disagreement on the company's value,
Brookfield Is Said to Plan to Walk Away From Grifols Bid
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation for the Spanish drug maker, according to people familiar with the matter.
Grifols drops as Brookfield is said to drop take-private bid
Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma therapeutics company private. Read more here.
Grifols Family Says It Won’t Back Another Take-Private Deal
The Grifols family won’t support a new bid by a third-party to take its namesake drug-maker private amid indications that ...
FiercePharma7d
Plasma specialist Grifols shrugs off private equity firm Brookfield's potential €6.5B takeover offer
With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...
Grifols spikes as banks reportedly finalize offers for buyout debt deal
Grifols (GRFS) stock gains as banks aim to finalize an €11B debt package for Brookfield's (BAM) plan to take the healthcare ...
Brookfield drops US$6.8-billion offer to buy drugmaker Grifols
Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb ...
Canadian Fund Drops Bid For Spanish Pharma Firm Grifols
Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following disagreement over its valuation.
Key deals this week: Amcor, ONEOK, Grifols, N-able and more
Packaging solutions company Amcor (AMCR) has agreed to acquire peer Berry Global Group (BERY) in an $8.4B all-stock ...